Marine drugs, derived from marine organisms, have been used for centuries and show significant potential for pharmaceutical applications, including cancer treatment and anti-inflammatory properties. They can be classified into categories such as anti-neoplastic agents, cardiovascular active drugs, and marine toxins, with recent discoveries enhancing their clinical relevance. Despite numerous promising compounds, few have progressed to clinical use, highlighting the need for continued research in this field.